½ÃÀ庸°í¼­
»óǰÄÚµå
1600545

Ç÷¾×¹é ½ÃÀå : À¯Çü, Àç·á, »ç¿ë¼º, ÃÖÁ¾ ¿ëµµº° - ¼¼°è ¿¹Ãø(2025-2030³â)

Blood Bags Market by Type (Double, Quadruple, Single), Material (Polyethylene Terephthalate, Polyolefins, Polyvinyl Chloride), Usability, End-Use - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 187 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Ç÷¾×¹é ½ÃÀåÀº 2023³â¿¡ 5¾ï 2,617¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í 2024³â¿¡´Â 5¾ï 6,167¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, CAGR 6.83%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 8¾ï 3,609¸¸ ´Þ·¯¿¡ ´ÞÇÒ Àü¸ÁÀÔ´Ï´Ù.

Ç÷¾×¹éÀº Ç÷¾×°ú ±× ¼ººÐ ¼öÁý, º¸°ü, ó¸®, ¼öÇ÷ À§ÇØ(¶§¹®¿¡) ¼³°èµÈ Çʼö ÀÇ·á±â±âÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ¹éÀº »ýü ÀûÇÕ¼º°ú ³»±¸¼ºÀ» È®º¸ÇÏ´Â DEHP °¡¼ÒÁ¦µéÀÌ PVCµîÀÇ Àç·á·Î ±¸¼ºµÇ¾î ÀÖ´Â °ÍÀÌ ¸¹½À´Ï´Ù. Ç÷¾×¹é Çʿ伺Àº ÀÇ·á ÇöÀå, ƯÈ÷ ¼öÇ÷ ÀÇ·á, Ç÷¾×ÇÐ, ¿Ü°úÇп¡¼­ ¸Å¿ì Áß¿äÇϰí, Ç÷¾×°ú ÀûÇ÷±¸, Ç÷Àå, Ç÷¼ÒÆÇµîÀÇ Ç÷¾× ¼ººÐ È®½ÇÇÑ °ø±ÞÀ» º¸ÁõÇÕ´Ï´Ù. ¿ëµµ´Â º´¿ø, Ŭ¸®´Ð, Ç÷¾×ÀºÇà, ¿¬±¸¼Ò¿¡ À̸£°í, ÃÖÁ¾»ç¿ëÀÚ¿¡´Â ÀÇ·á Àü¹®°¡, ¿¬±¸ÀÚ, ÇåÇ÷ ¼¾Å͵îÀÌ Æ÷ÇԵ˴ϴÙ. ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÏ´Â ÁÖ¿ä ¿äÀο¡´Â ¾ÈÀüÇÑ ¼öÇ÷ ÀýÂ÷¿¡ ´ëÇÑ ÀǽÄÀÇ °í¾ç°ú Çʿ伺, ¿Ü°ú ¼ö¼ú Áõ°¡, °í·ÉÈ­, Ç÷¾×¹é ±â¼ú Áøº¸µîÀÌ ÀÖ½À´Ï´Ù. ½ÅÈï ±¹°¡´Â ÀÇ·á ÀÎÇÁ¶ó °³¼±, ÀÚ¹ßÀûÀÎ ÇåÇ÷ Ȱµ¿À» Áö¿øÇÏ´Â Á¤ºÎ ÀÌ´Ï¼ÅÆ¼ºê¿¡ ÀÇÇØ Å« ½ÃÀå ±âȸ¸¦ °¡Á®¿À°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±âȸ¸¦ »ì¸®±â À§ÇØ, ±â¾÷Àº º¸Á¸ ±â°£ ¿¬Àå, ¹«±Õ¼º Çâ»ó, Æí¸®ÇÑ »ç¿ëÀ» º¸ÁõÇϴ ÷´Ü Àç·á³ª ¼³°è Á¦Ç°À» °³¹ßÇÏ´Â °ÍÀ¸·Î Çõ½ÅÀ» ÀÏÀ¸Å³ ¼ö ÀÖ½À´Ï´Ù. ±×·¯³ª, ½ÃÀåÀº ¾ö°ÝÇÑ ±ÔÁ¦ ¿ä°Ç, ¿À¿° ¸®½ºÅ©, Á¦Á¶ ºñ¿ë¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ÁÖ¿ä ¿ø·á ÇÑÁ¤ÀûÀÎ °¡¿ë¼ºÀ̶ó°í ÇÏ´Â °úÁ¦¿¡ Á÷¸éÇϰí ÀÖ½À´Ï´Ù. ½ÃÀå ¼ºÀå °¡´É¼ºÀº ÀÌ·¯ÇÑ ±ÔÁ¦³ª °ø±Þ¸Á °úÁ¦¿¡ ÀÇÇØ¼­ ¹æÇØÇÒ ¼ö ÀÖÀ» °¡´É¼ºÀÌ ÀÖ½À´Ï´Ù. Çõ½ÅÀº PVC¿¡ ´ë½ÅÇϴ ģȯ°æ ¸ÅÆ®¸®¾ó °³¹ß, º¸´Ù ÁÁÀº Àç°í °ü¸®¸¦ À§ÇÑ RFID ±â¼ú ÅëÇÕ, ¿À¿°À» ¸·¾Æ Ç÷¾× Ãë±ÞÇØ ÀýÂ÷¸¦ °³¼±Çϱâ À§ÇÑ ¾ÈÀü ±â´É °­È­¿¡¼­ ޱ¸ÇÒ ¼ö ÀÖ½À´Ï´Ù. ½ÃÀå °æÀïÀº °ÝÈ­Çϰí ÀÖ¾î, ÁÖ¿ä ±â¾÷Àº ½ÅÁ¦Ç° ¹ß¸ÅÀ» À§ÇÑ ¿¬±¸°³¹ß, Áö¿ªÀû ¹üÀ§¸¦ È®´ëÇϱâ À§ÇÑ Àü·«Àû Á¦ÈÞ¿¡ ÅõÀÚÇϰí ÀÖ½À´Ï´Ù. ±â¼ú ÅëÇÕÀ» ÃÖ´ëÇÑÀ¸·Î Ȱ¿ëÇØ, ¿ø·á °úÁ¦¿¡ ´ëóÇÏ´Â °ÍÀ¸·Î, ±â¾÷Àº ÀÇ·á ½ÃÀå ÀÌ Áß¿ä ºÎ¹®À» À¯ÁöÇØ, ÀáÀçÀûÀ¸·Î ¼ºÀå½Ãų ¼ö ÀÖ½À´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁØ ¿¬µµ(2023³â) 5¾ï 2,617¸¸ ´Þ·¯
¿¹Ãø ¿¬(2024³â) 5¾ï 6,167¸¸ ´Þ·¯
¿¹Ãø ¿¬(2030³â) 8¾ï 3,609¸¸ ´Þ·¯
CAGR(%) 6.83%

½ÃÀå ¿ªÇÐ : ±Þ¼ÓÈ÷ ÁøÈ­ÇÏ´Â Ç÷¾×¹é ½ÃÀå ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ®À» °ø°³

Ç÷¾×¹é ½ÃÀåÀº ¼ö¿ä ¹× °ø±Þ ´ÙÀ̳ª¹ÍÇÑ »óÈ£ÀÛ¿ë¿¡ ÀÇÇØ¼­ º¯¸ð¸¦ ÀÌ·ç°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐ ÁøÈ­¸¦ ÀÌÇØÇÏ´Â °ÍÀ¸·Î, ±â¾÷Àº ÃæºÐÇÑ Á¤º¸¿¡ ±Ù°ÅÇÑ ÅõÀÚ °áÁ¤, Àü·«Àû ÀÇ»ç°áÁ¤, »õ·Î¿î ºñÁî´Ï½º ±âȸ ȹµæÀ» ½Ç½ÃÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µ¿ÇâÀ» Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÏ´Â °ÍÀ¸·Î, ±â¾÷Àº Á¤Ä¡Àû, Áö¿ª ¸ñÇ¥, ±â¼úÀû, »çȸÀû, °æÁ¦ÀûÀÎ ¿µ¿ª¿¡ °Ç³Ê°¡´Â ´Ù¾çÇÑ ¸®½ºÅ©¸¦ °æ°¨ÇÒ ¼ö ÀÖ´Â °Í°ú µ¿½Ã¿¡, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ëÀ̳ª ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ±³Åë»ç°í³ª ¿Ü»ó Áõ°¡¿¡ ÀÇÇÑ Ç÷¾× ¼ö¿ä Áõ°¡
    • ÇåÇ÷À» Àå·ÁÇÏ´Â Á¤ºÎ ÀÌ´Ï¼ÅÆ¼ºê¿Í ¾ÈÀüÇÑ Ç÷¾× º¸°ü¡¤¿î¼Û ¼­ºñ½º ¿ä±¸ Áõ°¡
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • PVC Àç·á ¾Ç¿µÇâ¿¡ °¡¼¼ÇØ Ç÷¾×¹é »ç¿ë¿¡ ÀÇÇØ ¹ß»ýÇÏ´Â À¯ÇØ Æó±â¹°
  • ½ÃÀå ±âȸ
    • Ç÷¾×¹é ºÎ¹® Áøº¸
    • ¼¼°èÀÇ Ç÷¾×ÀºÇà Áõ°¡
  • ½ÃÀåÀÌ ÇØ°áÇØ¾ß ÇÒ °úÁ¦
    • ¼öÇ÷Áß Ç÷¾× ¾ÈÀü °ü¸®¿Í Á¤È®ÇÑ Ç÷¾×¹é ¿Âµµ À¯Áö º¹ÀâÇÑ ¿ä°Ç

Porter's Five Forces : Ç÷¾×¹é ½ÃÀåÀ» ¾È³»ÇÏ´Â Àü·« Åø

Porter's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ½ÃÀå ±¸µµ °æÀï ±¸µµ¸¦ ÀÌÇØÇϱâ À§ÇÑ Áß¿ä ÅøÀÔ´Ï´Ù. Porter's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ °æÀïÀ» Æò°¡ÇØ, Àü·«Àû ±âȸ¸¦ ã±â À§ÇÑ ¸íÈ®ÇÑ ¹æ¹ýÀ» ±âÀçÇϰí ÀÖ½À´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå³» ¼¼·Âµµ¸¦ Æò°¡ÇØ, ½Å±Ô »ç¾÷ ¼öÀͼºÀ» ÆÇ´ÜÇϴµ¥ µµ¿òÀÌ µË´Ï´Ù. À̰͵é ÅëÂû¿¡ ÀÇÇØ ±â¾÷Àº ÀÚ»ç °­Á¡À» »ì·Á, ¾àÁ¡¿¡ ´ëÃ³ÇØ, ÀáÀçÀûÀÎ °úÁ¦¸¦ ȸÇÇÇÒ ¼ö À־´Ù °­ÀÎÇÑ ½ÃÀå Æ÷Áö¼Å´×À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : Ç÷¾×¹é ½ÃÀå ¿ÜºÎ·ÎºÎÅÍ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ãȯ°æ ¿äÀÎÀº Ç÷¾×¹é ½ÃÀå ½ÇÀû ¿ªÇÐÀ» Çü¼ºÇϴµ¥ À־ ¸Å¿ì Áß¿ä ¿ªÇÒÀ» ¿Ï¼öÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀÎ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» ¾È³»Çϱâ À§Çؼ­ ÇÊ¿äÇÑ Á¤º¸¸¦ ±âÀçÇϰí ÀÖ½À´Ï´Ù. PESTLE ¿äÀÎÀ» Á¶»çÇÏ´Â °ÍÀ¸·Î, ±â¾÷Àº ÀáÀçÀûÀÎ ¸®½ºÅ©¿Í ±âȸ¸¦ º¸´Ù ÁÁ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®¿¡ ÀÇÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£µµ, °æÁ¦ µ¿Çâ º¯È­¸¦ ¿¹ÃøÇØ, ¾ÕÀ» ¿¹ÃøÇÑ Àû±ØÀûÀÎ ÀÇ»ç°áÁ¤À» ½Ç½ÃÇÒ Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® : Ç÷¾×¹é ½ÃÀå °æÀï ±¸µµ ÆÄ¾Ç

Ç÷¾×¹é ½ÃÀå »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®¿¡ ÀÇÇØ º¥´õ ½ÇÀûÀ» Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¸ÅÃâ, °í°´ ±â¹Ý, ¼ºÀå·üµîÀÇ ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ´Â °ÍÀ¸·Î, °æÀï»ó Æ÷Áö¼Å´×À» ºÐ¸íÈ÷ ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®¿¡ ÀÇÇØ ½ÃÀå ÁýÁß, ºÎ¹® È­, ÅëÇÕ µ¿ÇâÀÌ ¹àÇôÁ®, º¥´õ´Â °æÀïÀÌ °ÝÈ­ÇÏ´Â °¡¿îµ¥ ÀÚ»ç ÁöÀ§¸¦ ³ôÀÌ´Â Àü·«Àû ÀÇ»ç°áÁ¤À» ½Ç½ÃÇϱâ À§Çؼ­ ÇÊ¿äÇÑ Áö°ßÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º : Ç÷¾×¹é ½ÃÀå º¥´õ ÆÛÆ÷¸Õ½º Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â Ç÷¾×¹é ½ÃÀå¿¡¼­ º¥´õ¸¦ Æò°¡Çϱâ À§ÇÑ Áß¿ä ÅøÀÔ´Ï´Ù. ÀÌ ¸ÅÆ®¸¯½º¿¡ ÀÇÇØ ºñÁî´Ï½º Á¶Á÷Àº º¥´õ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¿¡ ±Ù°ÅÇØ Æò°¡ÇÏ´Â °ÍÀ¸·Î, ¸ñÇ¥¿¡ µû¸¥ ÃæºÐÇÑ Á¤º¸¿¡ ±Ù°ÅÇÑ ÀÇ»ç°áÁ¤À» ½Ç½ÃÇÒ ¼ö ÀÖ½À´Ï´Ù. 4°³ »óÇÑÀº º¥´õ¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ±¸ºÐÇØ, »ç¿ëÀÚ°¡ Àü·« ¸ñÇ¥·Î ÃÖÀûÀÎ ÆÄÆ®³Ê³ª ¼Ö·ç¼ÇÀ» ƯÁ¤Çϴµ¥ µµ¿òÀÌ µË´Ï´Ù.

º» º¸°í¼­´Â ÁÖ¿ä ÁÖ¸ñ ºÎ¹®À» ¸Á¶óÇÑ Á¾ÇÕÀû½ÃÀå ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1.½ÃÀå ħÅõµµ : »ê¾÷ ÁÖ¿ä ±â¾÷ ±¤¹üÀ§ÇÑ µ¥ÀÌÅ͸¦ Æ÷ÇÔÇÑ ÇöÀç ½ÃÀå ȯ°æ »ó¼¼ÇÑ ¸®ºä.

2.½ÃÀå °³Ã´µµ : ½ÅÈï ½ÃÀå ¼ºÀå ±âȸ¸¦ ƯÁ¤ÇØ, ±âÁ¸ ºÎ¹® È®´ë °¡´É¼ºÀ» Æò°¡ÇØ, ÇâÈÄ ¼ºÀåÀ» ÇâÇÑ Àü·«Àû ·Îµå¸ÊÀ» ±âÀçÇϰí ÀÖ½À´Ï´Ù.

3.½ÃÀå ´Ù¾çÈ­ : ÃÖ±Ù Á¦Ç° ¹ß¸Å, ¹Ì°³Ã´ Áö¿ª, »ê¾÷ ÁÖ¿ä Áøº¸, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4.°æÀï Æò°¡¿Í Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÇÏ°Ô ºÐ¼®ÇÏ°í ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦±â°ü ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ ±â¼ú Áøº¸µîÀ» °ËÁõ ÇÕ´Ï´Ù.

5.Á¦Ç° °³¹ß°ú Çõ½Å : ÇâÈÄ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÑ´Ù°í ±â´ëµÇ´Â ÃÖ÷´Ü ±â¼ú, ¿¬±¸°³¹ß Ȱµ¿, Á¦Ç° Çõ½ÅÀ» ÇÏÀ̶óÀÌÆ® Çϰí ÀÖ½À´Ï´Ù.

¶ÇÇÑ ÀÌÇØ°ü°èÀÚ°¡ ÃæºÐÇÑ Á¤º¸¸¦ ¾òÀº ´ÙÀ½ ÀÇ»ç°áÁ¤ ÇÒ ¼ö ÀÖµµ·Ï, Áß¿ä Áú¹®¿¡µµ ´äÇϰí ÀÖ½À´Ï´Ù.

1.ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå ¿¹ÃøÀº?

2.ÃÖ°í ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, Áö¿ªÀº ¾îµò°¡?

3.½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ ¿µÇâÀ̶õ?

4.ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5.º¥´õ ½ÃÀå Âü¿©¡¤Ã¶Åð Àü·« ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÔ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±âȸ
    • °úÁ¦
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ¹ý·ü
    • ȯ°æ

Á¦6Àå Ç÷¾×¹é ½ÃÀå : À¯Çüº°

  • ¼­·Ð
  • Double
  • Quadruple
  • Single
  • Triple

Á¦7Àå Ç÷¾×¹é ½ÃÀå : Àç·áº°

  • ¼­·Ð
  • Æú¸®¿¡Æ¿·» Å×·¹ÇÁÅ»·¹ÀÌÆ®
  • Æú¸®¿Ã·¹ÇÉ
  • Æú¸®¿°È­ºñ´Ò

Á¦8Àå Ç÷¾×¹é ½ÃÀå : »ç¿ë¼ºº°

  • ¼­·Ð
  • ȸ¼ö ¹é
  • ¿î¼Û ¹é

Á¦9Àå Ç÷¾×¹é ½ÃÀå : ÃÖÁ¾ ¿ëµµº°

  • ¼­·Ð
  • Ç÷¾×ÀºÇà
  • º´¿ø

Á¦10Àå ¾Æ¸Þ¸®Ä«ÀÇ Ç÷¾×¹é ½ÃÀå

  • ¼­·Ð
  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦11Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ Ç÷¾×¹é ½ÃÀå

  • ¼­·Ð
  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦12Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ Ç÷¾×¹é ½ÃÀå

  • ¼­·Ð
  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦13Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®, 2023³â
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023³â
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®

±â¾÷ ¸®½ºÆ®

  • Neomedic
  • B L Lifesciences Private Limited
  • Grifols, S.A
  • Olidef Medical
  • Shandong Weigao Group Medical Polymer Co.,Ltd.
  • Alvedia
  • KIEFEL GmbH
  • The Metrix Company
  • Suru International Pvt. Ltd.
  • JMS Co., Ltd.
  • HAEMONETICS CORPORATION
  • SB-Kawasumi Laboratories, Inc.
  • Fresenius SE & Co. KGaA
  • HANSLER MEDICAL GMBH
  • Lmb Technologie GmbH
  • Maco Pharma SAS
  • Narang Medical Limited
  • Mitra Industries Pvt. Ltd.
  • HLL Lifecare Limited
  • AdvaCare Pharma
  • Inovet
  • Suzhou Sinomed Co., Ltd.
  • RENOLIT SE
  • Poly Medicure Limited
  • Qingdao Sinoland International Trade Co., Ltd.
  • TROGE MEDICAL GmbH
  • Demophorius Limited
  • Terumo Corporation
  • Xindray Medical International Co., Ltd.
  • Advin Health Care
LSH 24.12.06

The Blood Bags Market was valued at USD 526.17 million in 2023, expected to reach USD 561.67 million in 2024, and is projected to grow at a CAGR of 6.83%, to USD 836.09 million by 2030.

Blood bags are essential medical devices designed for the collection, storage, processing, and transfusion of blood and its components. These bags often comprise materials such as PVC with DEHP plasticizers, which ensure biocompatibility and durability. The necessity of blood bags is pivotal in medical settings, particularly in transfusion medicine, hematology, and surgery, ensuring a reliable supply of blood and blood components like red blood cells, plasma, and platelets. The application extends across hospitals, clinics, blood banks, and research labs, with end-users including healthcare professionals, researchers, and blood donation centers. Key factors driving market growth include increasing awareness and necessity for safe blood transfusion procedures, rising surgical procedures, an aging population, and advancements in blood bag technology. Emerging economies present significant market opportunities due to improving healthcare infrastructure and government initiatives supporting voluntary blood donation drives. To capitalize on these opportunities, companies could innovate by developing products with advanced materials or designs that ensure longer shelf life, enhanced sterility, and ease of use. However, the market faces challenges like stringent regulatory requirements, risks of contamination, and limited availability of key raw materials impacting manufacturing costs. The potential for market growth can be hampered by these regulatory and supply chain challenges. Innovation can be explored in the development of eco-friendly materials as an alternative to PVC, integrating RFID technology for better inventory management, and enhancing safety features to prevent contamination and improve blood handling procedures. The market nature is competitive with key players investing in research and development for new product launches and strategic partnerships to expand their geographical reach. By maximizing technological integration and addressing raw material challenges, companies can sustain and potentially grow in this vital segment of the healthcare market.

KEY MARKET STATISTICS
Base Year [2023] USD 526.17 million
Estimated Year [2024] USD 561.67 million
Forecast Year [2030] USD 836.09 million
CAGR (%) 6.83%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Blood Bags Market

The Blood Bags Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing number of road accidents and trauma cases creating need for blood
    • Government initiatives encouraging blood donations and rising need for safe blood storage and transportation services
  • Market Restraints
    • Harmful waste produced due to usage of blood bags along with adverse impact of PVC material
  • Market Opportunities
    • Advancements in the blood bags field
    • Increasing number of blood banks globally
  • Market Challenges
    • Managing the blood safety during transfusion and complex requirement of maintaining precise blood bag temperature

Porter's Five Forces: A Strategic Tool for Navigating the Blood Bags Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Blood Bags Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Blood Bags Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Blood Bags Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Blood Bags Market

A detailed market share analysis in the Blood Bags Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Blood Bags Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Blood Bags Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Blood Bags Market, highlighting leading vendors and their innovative profiles. These include Neomedic, B L Lifesciences Private Limited, Grifols, S.A, Olidef Medical, Shandong Weigao Group Medical Polymer Co.,Ltd., Alvedia, KIEFEL GmbH, The Metrix Company, Suru International Pvt. Ltd., JMS Co., Ltd., HAEMONETICS CORPORATION, SB-Kawasumi Laboratories, Inc., Fresenius SE & Co. KGaA, HANSLER MEDICAL GMBH, Lmb Technologie GmbH, Maco Pharma SAS, Narang Medical Limited, Mitra Industries Pvt. Ltd., HLL Lifecare Limited, AdvaCare Pharma, Inovet, Suzhou Sinomed Co., Ltd., RENOLIT SE, Poly Medicure Limited, Qingdao Sinoland International Trade Co., Ltd., TROGE MEDICAL GmbH, Demophorius Limited, Terumo Corporation, Xindray Medical International Co., Ltd., and Advin Health Care.

Market Segmentation & Coverage

This research report categorizes the Blood Bags Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Double, Quadruple, Single, and Triple.
  • Based on Material, market is studied across Polyethylene Terephthalate, Polyolefins, and Polyvinyl Chloride.
  • Based on Usability, market is studied across Collection Bag and Transfer Bag.
  • Based on End-Use, market is studied across Blood Banks and Hospital.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing number of road accidents and trauma cases creating need for blood
      • 5.1.1.2. Government initiatives encouraging blood donations and rising need for safe blood storage and transportation services
    • 5.1.2. Restraints
      • 5.1.2.1. Harmful waste produced due to usage of blood bags along with adverse impact of PVC material
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements in the blood bags field
      • 5.1.3.2. Increasing number of blood banks globally
    • 5.1.4. Challenges
      • 5.1.4.1. Managing the blood safety during transfusion and complex requirement of maintaining precise blood bag temperature
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Increasing demand for single blood bags as they are cost-effective and straightforward compared to multi-component alternatives
    • 5.2.2. End-Use: Significant use of blood bags by the blood blanks
    • 5.2.3. Usability: Growing popularity of transfer bags for securely transport blood samples
    • 5.2.4. Material: Rising adoption of polyvinyl chloride (PVC) due to its high durability and lightweight properties
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Blood Bags Market, by Type

  • 6.1. Introduction
  • 6.2. Double
  • 6.3. Quadruple
  • 6.4. Single
  • 6.5. Triple

7. Blood Bags Market, by Material

  • 7.1. Introduction
  • 7.2. Polyethylene Terephthalate
  • 7.3. Polyolefins
  • 7.4. Polyvinyl Chloride

8. Blood Bags Market, by Usability

  • 8.1. Introduction
  • 8.2. Collection Bag
  • 8.3. Transfer Bag

9. Blood Bags Market, by End-Use

  • 9.1. Introduction
  • 9.2. Blood Banks
  • 9.3. Hospital

10. Americas Blood Bags Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Blood Bags Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Blood Bags Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. BetaLife to Showcase Its AI Powered Health Tech Solution for Advancing Health Equity at GITEX AFRICA 2023 The Largest Tech Event
    • 13.3.2. ICMR Runs Trial of Blood Bag Delivery Under iDrone Initiative
    • 13.3.3. Trial Run of Blood Bag Delivery under the iDrone Initiative of ICMR successfully conducted
    • 13.3.4. DBT Institute Develops Novel Bags To Increase Shelf Life Of Blood
    • 13.3.5. Maco Medlab: Joint-Venture of 2 blood transfusion players
    • 13.3.6. For Start-Ups, Industry, Kerala Doubles Financial Assistance to INR 10 Million
    • 13.3.7. NBSC Calls for Investment in Blood Bank
    • 13.3.8. U.S. Gov awards USD 10.6 Million Freeze-Dried Plasma Contract to Terumo

Companies Mentioned

  • 1. Neomedic
  • 2. B L Lifesciences Private Limited
  • 3. Grifols, S.A
  • 4. Olidef Medical
  • 5. Shandong Weigao Group Medical Polymer Co.,Ltd.
  • 6. Alvedia
  • 7. KIEFEL GmbH
  • 8. The Metrix Company
  • 9. Suru International Pvt. Ltd.
  • 10. JMS Co., Ltd.
  • 11. HAEMONETICS CORPORATION
  • 12. SB-Kawasumi Laboratories, Inc.
  • 13. Fresenius SE & Co. KGaA
  • 14. HANSLER MEDICAL GMBH
  • 15. Lmb Technologie GmbH
  • 16. Maco Pharma SAS
  • 17. Narang Medical Limited
  • 18. Mitra Industries Pvt. Ltd.
  • 19. HLL Lifecare Limited
  • 20. AdvaCare Pharma
  • 21. Inovet
  • 22. Suzhou Sinomed Co., Ltd.
  • 23. RENOLIT SE
  • 24. Poly Medicure Limited
  • 25. Qingdao Sinoland International Trade Co., Ltd.
  • 26. TROGE MEDICAL GmbH
  • 27. Demophorius Limited
  • 28. Terumo Corporation
  • 29. Xindray Medical International Co., Ltd.
  • 30. Advin Health Care
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦